~~<i id='DC4549DE07'><strike id='DC4549DE07'><tt id='DC4549DE07'><pre id='DC4549DE07'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

comprehensive

author：hotspot 2025-09-28 22:53:23 - browse：42979

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Change Healthcare: What is it, why does its cyberattack matter?

hotspot

leisure time

Wikipedia

focus

leisure time

ChinesescientistHeJiankuiclaimshehelpedmakeworld'sfirstgeneticallyeditedbabies:twingirlswhoseDNAhesa

WSS

Chinese researcher claims birth of first gene

First over

The public health thinking behind the CDC’s new Covid guidance

Longer MASH drug regimen improved liver, Akero study finds

What Kate Middleton's cancer revelation might teach the world

He's 19 months old and has one of the world’s rarest diseases

knowledge

comprehensive

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Psychedelics group wrestles with new pharma identity

Pregnant women don't need prenatal multivitamins, study concludes

Wildfire smoke exposes gaps in outdoor worker protections

Pfizer, Moderna say biotech, pharma drug development is a sprint

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Ozempic has benefits for kidney disease as well as diabetes

Virginia high school admissions case could be legal follow

6 surprising facts about sugar

leisure time

Cancer, immunology, HIV research ensnared in fetal tissue politics

'Patient friction coefficient' can gauge a clinical trial's patient burden

Bring on the sabbaticals for nurses

Erich Jarvis studies song birds to learn about human stuttering

Pregnancy ages women, but effects reverse after delivery

Immune cells and nerve overgrowth may explain recurring UTI pain

leisure time

Wikipedia

focus

leisure time